Notice to Extend the Expiration Date of PAR-12-238 "Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R21)"
PAR-12-238
Notice Number: NOT-DA-15-078
Key Dates
Release Date: August 6, 2015
PAR-12-238
Issued by
National Institute on Drug Abuse (NIDA)
Purpose
This Notice extends the expiration date for PAR-12-238 "Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R21)" by one funding cycle.
Current Expiration Date: September 8, 2015
New Expiration Date: January 8, 2016
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
Aidan Hampson PhD.
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-8039
Email: [email protected]
Department of Health
and Human Services (HHS)
and Human Services (HHS)
